Catherine Azar is an Oncology physician affiliated with Arizona Oncology. OpenAlex indexes 18 publications with 2,109 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3945 E Paradise Falls Dr Ste 105
Tucson, AZ 857126686
Telephone
502-689-7030Provider last certified this registry record 26 Aug 2020.
Industry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cardinal Health 110 LLCProgram year20251 payment
- Janssen Biotech, Inc.Program year20252 payments
- Incyte CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
63.1%Iron, parenteral preparations49.5%Ferric carboxymaltose100%Part B, office-administered≥23 patientsErythropoiesis-stimulating Agent13.5%Darbepoetin alfa100%Part B, office-administered≥11 patients+ 3 more classes in this area
Musculoskeletal
31.3%RANK Ligand Inhibitor31.2%Denosumab100%Xgeva0%Part D + Part B<11 patientsBisphosphonate0.2%Zoledronic acid100%Part B, office-administered≥20 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.8%Serotonin-3 Receptor Antagonist1.7%Granisetron hydrochloride56%Palonosetron hcl43%Ondansetron Hcl1%Part D + Part B<11 patientsAntidiarrheal microorganisms0.1%Folic Acid100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
Breast Cancer Research and Treatment
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”